Obesity is a precursor condition of several diseases, among them hypertension. The sympathoexcitatory neurons of the rostral ventrolateral medulla (RVLM), which directly innervate sympathetic preganglionic neurons in the intermediolateral cell columns of the spinal cord, are a possible target for cardiovascular modulation by obesity, and glutamatergic neurotransmission has an important role. Thus, the aim of this study was to determine the effect of glutamate microinjection into the RVLM in control and MSG obese rats. Obesity was induced by intradermal administration of 4 mg/g of monosodium glutamate (MSG) or hyperosmotic saline (control = CTR) in the first 5 days of life in male Wistar rats. At 90 days old, the animals were submitted to guide cannulae implantation to the RVLM for unilateral microinjection of L‐glutamate (5 nmol/100 nl) in conscious state for recording for mean arterial pressure (MAP) and heart rate (HR). There was no difference in MAP and HR at baseline among the experimental groups (CTR: 112 ± 2 mmHg, 362 ± 14 bpm; MSG: 106 ± 3 mmHg, 389 ± 13 bpm). Unilateral microinjection of l‐glutamate produced an increase in MAP in CTR and MSG groups, however, the magnitude of this response was higher in obese rats (CTR: 44 ± 3; MSG: 56 ± 2, p=0,02). The excitation of the RVLM with glutamate decreased HR to levels that were not statistically different between groups (CTR: −26 ± 19 bpm; MSG: −45 ± 37 bpm). The present results suggest that MSG obese rats may have elevated sympathetic nerve activity originated from the activity of RVLM neurons.
Read full abstract